Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Destinasi Tirta Nusantara Tbk (PDES) Price & Performance

UBC Medical Indonesia Tbk.Trade
Destinasi Tirta Nusantara TbkTrade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Destinasi Tirta Nusantara Tbk — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while Destinasi Tirta Nusantara Tbk trades at Rp394 (market cap 283.14B, 308K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.2× Destinasi Tirta Nusantara Tbk's market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 308K). Which is the better fit depends on your goals.

LABSPDES
Market Cap
635.95B283.14B
Volume
843K308K
Lot
8.43K3.08K
Turnover
137.6M119.93M
Average Price
163.22389.39
Value
137.6M119.93M
Indicative Equilibrium Price
165394
Indicative Equilibrium Volume
24665

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
PDES
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Destinasi Tirta Nusantara Tbk

PT Destinasi Tirta Nusantara Tbk (the company) was established on 30 Oct 1999 based on Notaries Deed No. 36 and the deed of establishment was approved by the the Ministry of Justice dated Feb 23, 2000. The Company’s articles of association has been amended several times, most recently by notarial deed No. 187 and No.136 of Wijanto Suwongso, S.H., dated Jun 28, 2007 and 24 Oct 07, concerning among others, increase authorized, Paid up Capital, par value and public offering.

Read more on PDES